{"@id":"https://bioecon.ru/technology/ai-biomarker-drug-development-analytics/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://en.bioecon.ru/technology/ai-biomarker-drug-development-analytics/","json":"https://en.bioecon.ru/api/v1/technology/ai-biomarker-drug-development-analytics/index.json"},"id":"ai-biomarker-drug-development-analytics","industries":["bio-ai","digital-robotics","research-tools","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/bio-ai/","https://bioecon.ru/industries/digital-robotics/","https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/biohaven/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/rev-genomics/","https://bioecon.ru/companies/fresenius/","https://bioecon.ru/companies/unibio/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/schr-dinger/","https://bioecon.ru/companies/euphoria-retreat/"]},"maturity":8,"name":"AI-Driven Single-Cell Phenotypic Biomarker Discovery and Patient Stratification Analytics","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"synbio-enabling","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"High-dimensional single-cell data preprocessing and batch correction"},{"n":2,"title":"Self-supervised representation learning and rare cell cluster discovery"},{"n":3,"title":"Explainable feature attribution and molecular signature extraction"},{"n":4,"title":"Companion diagnostic (CDx) algorithm validation and transfer"}],"summary":"Clinical-stage AI bioinformatics platform applying advanced self-supervised machine learning to single-cell RNA-sequencing (scRNA-seq) and high-dimensional flow/mass cytometry data, identifying ultra-rare responsive cellular phenotypes and novel predictive biomarker signatures that stratify patients in oncology and autoimmune clinical trials.","url":"/technology/ai-biomarker-drug-development-analytics/","verified":"2026-11-22"}